Literature DB >> 15793278

Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury.

Karl A Nath1, Joseph P Grande, Anthony J Croatt, Elena Frank, Noel M Caplice, Robert P Hebbel, Zvonimir S Katusic.   

Abstract

Ischemic injury is invoked as a mechanism contributing to end-organ damage and other complications of sickle cell disease (SCD). However, the intrinsic sensitivity of tissues in SCD to ischemic insults has never been addressed. We examined the effect of renal ischemia in a transgenic mouse expressing human sickle hemoglobin. Twenty-four hours after bilateral, total renal artery occlusion for 15 minutes, transgenic sickle mice exhibited worse renal function and more marked histological injury. With bilateral renal ischemia of greater duration (22.5 minutes), and after 6 hours, transgenic sickle mice exhibited massive vascular congestion, sickling of red blood cells, more marked histological injury in the kidney, and more prominent congestion in the capillary beds in the lungs and heart. Additionally, serum amyloid P-component, the murine homologue of C-reactive protein, was markedly increased in transgenic sickle mice as compared to wild-type mice. Twenty-four hours after bilateral renal ischemia for 22.5 minutes, transgenic sickle mice exhibited 28% mortality, with no mortality observed in any other group. With bilateral renal ischemia of short or long duration, renal expression of caspase-3 was most prominent in transgenic sickle mice subjected to ischemia. Thus, renal ischemia in this murine model induces more severe renal injury and extrarenal complications. We conclude that tissues in SCD exhibit heightened vascular congestion and sensitivity to ischemia and that clinically apparent or silent episodes of ischemia may contribute to the complications of SCD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15793278      PMCID: PMC1602372          DOI: 10.1016/S0002-9440(10)62318-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  56 in total

1.  Vascular occlusion and ischemic infarction in sickle cell disease.

Authors:  P KIMMELSTEIL
Journal:  Am J Med Sci       Date:  1948-07       Impact factor: 2.378

2.  Renal ischemic-reperfusion injury in L-selectin-deficient mice.

Authors:  H Rabb; G Ramirez; S R Saba; D Reynolds; J Xu; R Flavell; S Antonia
Journal:  Am J Physiol       Date:  1996-08

Review 3.  The pathophysiology of vascular obstruction in the sickle syndromes.

Authors:  D K Kaul; M E Fabry; R L Nagel
Journal:  Blood Rev       Date:  1996-03       Impact factor: 8.250

Review 4.  Sickle cell nephropathy.

Authors:  R J Falk; J C Jennette
Journal:  Adv Nephrol Necker Hosp       Date:  1994

Review 5.  Tubulointerstitial changes as a major determinant in the progression of renal damage.

Authors:  K A Nath
Journal:  Am J Kidney Dis       Date:  1992-07       Impact factor: 8.860

6.  Responses of the normal rat kidney to sequential ischemic events.

Authors:  R A Zager; M S Jurkowitz; A J Merola
Journal:  Am J Physiol       Date:  1985-07

7.  The contribution of vascular obstruction to the functional defect that follows renal ischemia.

Authors:  J Mason; J Welsch; J Torhorst
Journal:  Kidney Int       Date:  1987-01       Impact factor: 10.612

8.  Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality.

Authors:  D R Powars; D D Elliott-Mills; L Chan; J Niland; A L Hiti; L M Opas; C Johnson
Journal:  Ann Intern Med       Date:  1991-10-15       Impact factor: 25.391

9.  A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbS-Antilles results in increased phenotypic severity.

Authors:  M E Fabry; A Sengupta; S M Suzuka; F Costantini; E M Rubin; J Hofrichter; G Christoph; E Manci; D Culberson; S M Factor; R L Nagel
Journal:  Blood       Date:  1995-09-15       Impact factor: 22.113

10.  Red cell trapping and postischemic renal blood flow. Differences between the cortex, outer and inner medulla.

Authors:  P Olof; A Hellberg; O Källskog; M Wolgast
Journal:  Kidney Int       Date:  1991-10       Impact factor: 10.612

View more
  39 in total

1.  Vasculature and kidney complications in sickle cell disease.

Authors:  Karl A Nath; Zvonimir S Katusic
Journal:  J Am Soc Nephrol       Date:  2012-03-22       Impact factor: 10.121

Review 2.  The role of CD47 in pathogenesis and treatment of renal ischemia reperfusion injury.

Authors:  Jeffrey S Isenberg; David D Roberts
Journal:  Pediatr Nephrol       Date:  2018-11-03       Impact factor: 3.714

3.  Cerebrovascular disease associated with sickle cell pulmonary hypertension.

Authors:  Gregory J Kato; Matthew Hsieh; Roberto Machado; James Taylor; Jane Little; John A Butman; Tanya Lehky; John Tisdale; Mark T Gladwin
Journal:  Am J Hematol       Date:  2006-07       Impact factor: 10.047

Review 4.  Sickle cell disease: renal manifestations and mechanisms.

Authors:  Karl A Nath; Robert P Hebbel
Journal:  Nat Rev Nephrol       Date:  2015-02-10       Impact factor: 28.314

5.  Regulation of Mitochondrial Dynamics by Dynamin-Related Protein-1 in Acute Cardiorenal Syndrome.

Authors:  Maki Sumida; Kent Doi; Emi Ogasawara; Tetsushi Yamashita; Yoshifumi Hamasaki; Taro Kariya; Eiki Takimoto; Naoki Yahagi; Masaomi Nangaku; Eisei Noiri
Journal:  J Am Soc Nephrol       Date:  2015-02-02       Impact factor: 10.121

6.  Anomalous renal effects of tin protoporphyrin in a murine model of sickle cell disease.

Authors:  Julio P Juncos; Joseph P Grande; Narayana Murali; Anthony J Croatt; Luis A Juncos; Robert P Hebbel; Zvonimir S Katusic; Karl A Nath
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

7.  Severe anemia early in life as a risk factor for sickle-cell kidney disease.

Authors:  Inmaculada Aban; Sujatha Baddam; Lee M Hilliard; Thomas H Howard; Daniel I Feig; Jeffrey D Lebensburger
Journal:  Blood       Date:  2016-12-05       Impact factor: 22.113

8.  Acute inactivation of the VHL gene contributes to protective effects of ischemic preconditioning in the mouse kidney.

Authors:  Mitsuko Iguchi; Yoshihiko Kakinuma; Atsushi Kurabayashi; Takayuki Sato; Taro Shuin; Seung-Beom Hong; Laura S Schmidt; Mutsuo Furihata
Journal:  Nephron Exp Nephrol       Date:  2008-10-27

9.  Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease.

Authors:  Nathalie Sabaa; Lucia de Franceschi; Philippe Bonnin; Yves Castier; Giorgio Malpeli; Haythem Debbabi; Ariane Galaup; Micheline Maier-Redelsperger; Sophie Vandermeersch; Aldo Scarpa; Anne Janin; Bernard Levy; Robert Girot; Yves Beuzard; Christophe Leboeuf; Annie Henri; Stéphane Germain; Jean-Claude Dussaule; Pierre-Louis Tharaux
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

10.  Serum interleukin-6 and interleukin-8 are early biomarkers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: a case-control study.

Authors:  Kathleen D Liu; Christopher Altmann; Gerard Smits; Catherine D Krawczeski; Charles L Edelstein; Prasad Devarajan; Sarah Faubel
Journal:  Crit Care       Date:  2009-07-01       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.